21 patents currently held
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in Jun 2033. from the record
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
Jun 2033
Next term end
13
Patent families
When these terms end
Held patents by the year their term ends
notable patents
fee due within 90 days
all others
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Oct 2034 · High confidence
Also notable
Ends Nov 2036 · High confidence
Also notable
Ends Dec 2034 · High confidence
Methods and Compositions for Promoting the Structural Integrity of Scaffolds for Tissue Engineering
US 10,449,026
The most cited patent in this portfolio, cited by 44 later US patents, top 5% of utility patents granted in 2019 in our data. Protection runs to 2034.
Systems and Methods for Producing Gastrointestinal Tissues
US 10,265,153
Cited by 41 later US patents, top 10% of utility patents granted in 2019 in our data, and renewed at 2 of 3 maintenance windows. Protection runs to 2036.
Synthetic Scaffolds
US 11,284,987
Granted 2022. Computed term ends 2034.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Nov 26, 2026The maintenance fee for Analytical Methods (US 9,040,921) comes due Nov 26, 2026. Unpaid by May 26, 2027, it lapses early.
- 2 fees due Apr 22 to 29, 2027 · next Apr 22
- 1 fee due Jul 28, 2027The maintenance fee for Bioreactors and Uses Thereof (US 10,544,387) comes due Jul 28, 2027. Unpaid by Jan 28, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
What they patent
The 5 largest of its 13 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
| Systems and Methods for Producing Gastrointestinal Tissues | 3 in force | to Nov 2036 |
| Synthetic Scaffolds | 3 in force | to Dec 2034 |
| Method and Device for in Vivo Tissue Regeneration on the Interior Surface of Hollow Organs | 2 in force | to Jan 2040 |
| Method and Device for in Vivo Bronchus Regeneration | 2 in force | to Oct 2039 |
| Methods and Compositions for Promoting the Structural Integrity of Scaffolds for Tissue Engineering | 2 in force | to Oct 2034 |
Patents held now
Soonest term end first.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 12,042,369 | Methods and Compositions for Promoting the Structural Integrity of Scaffolds for Tissue Engineering In force · High confidence | In force | High confidence | |
| US 9,040,921 | Analytical Methods In force · High confidence | In force | High confidence | |
| US 12,383,391 | Synthetic Scaffolds In force · High confidence | In force | High confidence | |
| US 12,685,628 | Synthetic Scaffolds In force · High confidence | In force | High confidence | |
| US 9,918,463 | Bioreactor In force · High confidence | In force | High confidence | |
| US 10,457,905 | Bioreactor Connectors In force · High confidence | In force | High confidence | |
| US 11,485,943 | Bioreactor Connectors In force · High confidence | In force | High confidence | |
| US 10,544,387 | Bioreactors and Uses Thereof In force · High confidence | In force | High confidence | |
| US 9,877,822 | Engineered Tissue Scaffolds and Supports Therefor In force · High confidence | In force | High confidence | |
| US 10,449,026 | Methods and Compositions for Promoting the Structural Integrity of Scaffolds for Tissue Engineering In force · High confidence | In force | High confidence |
Also on record, not counted in the 21: 6 applications pending · 10 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.